Liver Systems Medicine Cancer - LiSyM-Cancer - is a multidisciplinary research network funded within the Federal Ministry of Research, Technology and Space program "Funding of a Systems Medicine Research Network for the Early Detection and Prevention of Liver Cancer" within the Framework of the National Decade Against Cancer.
Liver Systems Medicine Cancer - LiSyM-Krebs - ist ein multidisziplinäres Forschungsnetzwerk, das im Rahmen des Programms des Bundesministeriums für Bildung und Forschung (BMBF) "Förderung eines systemmedizinischen Forschungsnetzwerks zur Früherkennung und Prävention von Leberkrebs im Rahmen der Nationalen Dekade gegen Krebs" gefördert wird.
Company Details
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.lisym-cancer.org
- Competitors
- Chemical Engineering Journal (CEJ), sweet skin, Nami Therapeutics Corporation, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Farmaceutiska fakulteten • Uppsala universitet, St. Claraspital AG, Effizienz:Klasse GmbH, Bredehorst Clinic Medical Management GmbH, Bethesda Spital AG, Lucerne Clinic Switzerland.
Lisym-Cancer Questions
Lisym-Cancer's website is http://www.lisym-cancer.org
Lisym-Cancer's LinkedIn profile is https://www.linkedin.com/company/lisym-cancer
Lisym-Cancer's industry is
Research Services
Lisym-Cancer's top competitors are
Chemical Engineering Journal (Cej),
Sweet Skin,
Nami Therapeutics Corporation,
Helmholtz Institute For Pharmaceutical Research Saarland (Hips),
Farmaceutiska Fakulteten • Uppsala Universitet,
St. Claraspital Ag,
Effizienz:klasse Gmbh,
Bredehorst Clinic Medical Management Gmbh,
Bethesda Spital Ag,
Lucerne Clinic Switzerland.
Lisym-Cancer's categories are Research Services
